REPORT ID 13861

EMEA (Europe, Middle East and Africa) Remifentanil Hydrochloride Market Report 2017

Publish Date
22-Nov-17
Pages
109
Format
Electronic (PDF)

In this report, the EMEA Remifentanil Hydrochloride market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Remifentanil Hydrochloride for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Remifentanil Hydrochloride market competition by top manufacturers/players, with Remifentanil Hydrochloride sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GSK
    Macfarlan Smith
    Abbott
    Mylan
    Arevipharma
    AMRI
    ...

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    1mg/Pcs
    2mg/Pcs
    5mg/Pcs

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Remifentanil Hydrochloride for each application, including
    Endotracheal?intubation?operation
    Neurosurgery
    Outpatient?surgery
    Postoperative?analgesia
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Remifentanil Hydrochloride Market Report 2017
1 Remifentanil Hydrochloride Overview
    1.1 Product Overview and Scope of Remifentanil Hydrochloride
    1.2 Classification of Remifentanil Hydrochloride
        1.2.1 EMEA Remifentanil Hydrochloride Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Remifentanil Hydrochloride Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 1mg/Pcs
        1.2.4 2mg/Pcs
        1.2.5 5mg/Pcs
    1.3 EMEA Remifentanil Hydrochloride Market by Application/End Users
        1.3.1 EMEA Remifentanil Hydrochloride Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Endotracheal?intubation?operation
        1.3.3 Neurosurgery
        1.3.4 Outpatient?surgery
        1.3.5 Postoperative?analgesia
        1.3.6 Other
    1.4 EMEA Remifentanil Hydrochloride Market by Region
        1.4.1 EMEA Remifentanil Hydrochloride Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Remifentanil Hydrochloride (2012-2022)
        1.5.1 EMEA Remifentanil Hydrochloride Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Remifentanil Hydrochloride Revenue and Growth Rate (2012-2022)

2 EMEA Remifentanil Hydrochloride Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Remifentanil Hydrochloride Market Competition by Players/Manufacturers
        2.1.1 EMEA Remifentanil Hydrochloride Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Remifentanil Hydrochloride Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Remifentanil Hydrochloride Sale Price by Players (2012-2017)
    2.2 EMEA Remifentanil Hydrochloride (Volume and Value) by Type/Product Category
        2.2.1 EMEA Remifentanil Hydrochloride Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Remifentanil Hydrochloride Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Remifentanil Hydrochloride Sale Price by Type (2012-2017)
    2.3 EMEA Remifentanil Hydrochloride (Volume) by Application
    2.4 EMEA Remifentanil Hydrochloride (Volume and Value) by Region
        2.4.1 EMEA Remifentanil Hydrochloride Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Remifentanil Hydrochloride Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Remifentanil Hydrochloride Sales Price by Region (2012-2017)

3 Europe Remifentanil Hydrochloride (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Remifentanil Hydrochloride Sales and Value (2012-2017)
        3.1.1 Europe Remifentanil Hydrochloride Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Remifentanil Hydrochloride Revenue and Growth Rate (2012-2017)
    3.2 Europe Remifentanil Hydrochloride Sales and Market Share by Type
    3.3 Europe Remifentanil Hydrochloride Sales and Market Share by Application
    3.4 Europe Remifentanil Hydrochloride Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Remifentanil Hydrochloride Sales Volume by Countries (2012-2017)
        3.4.2 Europe Remifentanil Hydrochloride Revenue by Countries (2012-2017)
        3.4.3 Germany Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        3.4.4 France Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        3.4.5 UK Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        3.4.6 Russia Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        3.4.7 Italy Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)

4 Middle East Remifentanil Hydrochloride (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Remifentanil Hydrochloride Sales and Value (2012-2017)
        4.1.1 Middle East Remifentanil Hydrochloride Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Remifentanil Hydrochloride Revenue and Growth Rate (2012-2017)
    4.2 Middle East Remifentanil Hydrochloride Sales and Market Share by Type
    4.3 Middle East Remifentanil Hydrochloride Sales and Market Share by Application
    4.4 Middle East Remifentanil Hydrochloride Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Remifentanil Hydrochloride Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Remifentanil Hydrochloride Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        4.4.4 Israel Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        4.4.5 UAE Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        4.4.6 Iran Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)

5 Africa Remifentanil Hydrochloride (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Remifentanil Hydrochloride Sales and Value (2012-2017)
        5.1.1 Africa Remifentanil Hydrochloride Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Remifentanil Hydrochloride Revenue and Growth Rate (2012-2017)
    5.2 Africa Remifentanil Hydrochloride Sales and Market Share by Type
    5.3 Africa Remifentanil Hydrochloride Sales and Market Share by Application
    5.4 Africa Remifentanil Hydrochloride Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Remifentanil Hydrochloride Sales Volume by Countries (2012-2017)
        5.4.2 Africa Remifentanil Hydrochloride Revenue by Countries (2012-2017)
        5.4.3 South Africa Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Remifentanil Hydrochloride Sales and Growth Rate (2012-2017)

6 EMEA Remifentanil Hydrochloride Manufacturers/Players Profiles and Sales Data
    6.1 GSK
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Remifentanil Hydrochloride Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GSK Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Macfarlan Smith
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Remifentanil Hydrochloride Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Macfarlan Smith Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Abbott
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Remifentanil Hydrochloride Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Abbott Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Mylan
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Remifentanil Hydrochloride Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Mylan Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Arevipharma
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Remifentanil Hydrochloride Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Arevipharma Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 AMRI
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Remifentanil Hydrochloride Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AMRI Remifentanil Hydrochloride Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    ...

7 Remifentanil Hydrochloride Manufacturing Cost Analysis
    7.1 Remifentanil Hydrochloride Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Remifentanil Hydrochloride

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Remifentanil Hydrochloride Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Remifentanil Hydrochloride Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Remifentanil Hydrochloride Market Forecast (2017-2022)
    11.1 EMEA Remifentanil Hydrochloride Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Remifentanil Hydrochloride Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Remifentanil Hydrochloride Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Remifentanil Hydrochloride Price and Trend Forecast (2017-2022)
    11.2 EMEA Remifentanil Hydrochloride Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Remifentanil Hydrochloride Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Remifentanil Hydrochloride Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Remifentanil Hydrochloride Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Remifentanil Hydrochloride Sales Forecast by Type (2017-2022)
    11.7 EMEA Remifentanil Hydrochloride Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer